Surgical removal of an epiretinal membrane (ERM) is a relatively common procedure, often resulting in significant visual improvement. Several complications, however, are well recognized, and include cataract formation, retinal breaks and detachments, cystoid macular edema, retinal phototoxicity, and endophthalmitis.1Choroidal neovascularization (CNV) is a rare complication of ERM surgery, and, to our knowledge, only 3 cases have been reported in the literature.2- 4We report 3 additional cases of CNV after surgical removal of idiopathic macular puckers, and comment on the literature regarding this entity.
Case 1. A 47-year-old man complained of increasing metamorphopsia in his left eye for 3 years. His ophthalmic history was notable for myopia of 7.75 diopters, cataract surgery in his left eye at the age of 40 years, and a small retinal tear in the nasal periphery in the left eye treated with a laser. His visual acuity (VA) was 20/60 OS, and the result of a fundus examination revealed a macular pucker (Figure 1A). Examination results were unremarkable in the right eye. The patient underwent pars plana vitrectomy and an uncomplicated ERM peel using fine forceps.
For case 1, fundus photographs of when the patient was initially seen, showing an epiretinal membrane (ERM) with macular striae (A), and 2 months after ERM removal, showing elevation of the macula by a new and extensive subretinal membrane (B).
Four weeks postoperatively, the patient reported a central scotoma and blurred vision. Eight weeks postoperatively, his VA decreased to 20/800 OS and juxtafoveal CNV was noted on fundus examination and fluorescein angiography (FA) (Figure 1B and Figure 2A). The patient underwent pars plana vitrectomy, and the subretinal membrane was removed. Two weeks later, his VA was 20/125−1 OS and the results of a fundus examination revealed significant improvement (Figure 2B). However, 8 months postoperatively, the patient developed a rhegmatogenous retinal detachment requiring vitrectomy and silicone oil placement; his VA 2 years later was 20/500 OS.
For case 1, a corresponding fluorescein angiogram 2 months after epiretinal membrane removal documents intense focal hyperfluorescence consistent with fibrovascular ingrowth in the nasal macula (A) and a fundus photograph 2 weeks after subretinal membrane removal shows an improved macular appearance (B).
Case 2. A 77-year-old man complained of decreased VA in his right eye for 2 years. His VA was 20/80 OD. The results of an ophthalmic examination revealed cataracts in both eyes, a mild ERM in his left eye, and an ERM associated with cystic retinal changes in his right eye. The patient underwent uncomplicated pars plana vitrectomy and an ERM peel in his right eye using Tano forceps (Synergetics Inc, Wilsonville, Ore). A trace intraretinal hemorrhage was noted inferotemporal to the fovea postoperatively.
Four weeks postoperatively, the patient's VA improved to 20/50 OD. Because of a residual intraretinal hemorrhage, FA was performed, revealing no evidence of CNV.
Five months postoperatively, the patient developed metamorphopsia and his VA declined to 20/125 OD. The results of a fundus examination revealed an elevated grayish lesion temporal to the fovea. The FA showed classic extrafoveal CNV that was treated with laser photocoagulation. Three weeks following treatment, his VA was 20/100 OD. The FA showed no evidence of CNV. Seven weeks later, his VA remained stable at 20/100 OD.
Case 3. An 80-year-old man complained of deteriorating vision in his left eye 1 month after uneventful cataract extraction and intraocular lens implantation. His ocular history was significant for cataract extraction in his left eye and medically managed glaucoma in both eyes. The result of a fundus examination was unremarkable in his right eye and revealed a macular ERM and cystoid macular edema in his left eye, which was confirmed by FA. Eighteen months after cataract surgery, the cystoid macular edema had resolved; however, the patient's VA remained poor, at 20/50−1 OS, secondary to the ERM. A pars plana vitrectomy and membrane peel using Tano forceps were performed. Minimal surface bleeding was noted during the procedure; 1 week later, a focal intraretinal hemorrhage was seen nasal to the fovea and a preretinal hemorrhage was seen inferior to the fovea. One month postoperatively, the patient's VA was 20/200 OS. The FA showed classic extrafoveal CNV that was treated with laser photocoagulation.
Three weeks following laser photocoagulation, the patient's VA deteriorated further to 20/400 OS. The FA showed recurrence of subfoveal CNV, which was then treated with photodynamic therapy. The patient required 4 sessions of photodynamic therapy, 2, 5, 10, and 13½ months after ERM removal.
The FA 17 months following surgery showed subretinal fibrosis with no evidence of leakage. At the 2-year follow-up, the patient's VA remained poor, at 20/800 OS.
In this series, we report 3 cases of CNV that developed after idiopathic ERM removal. Three additional cases have been reported in the literature.2- 4Preoperatively, there was no evidence of age-related macular degeneration in any of the patients.
The mean duration of the ERM before surgery in the 6 cases was 22.6 months (range, 5 months to 4 years). Choroidal neovascularization was diagnosed between 1 month and 2 years postoperatively. The mean preoperative VA was 20/65 (range, 20/50-20/200). The CNV complexes were predominantly classic and were initially extrafoveal or juxtafoveal. Management included surgical removal, photocoagulation, and photodynamic therapy. The mean follow-up after CNV treatment was 1 year (range, 4-24 months). The mean final VA was 20/270 (range, 20/40-20/800). The visual outcome was largely poor when the follow-up interval was longer, and variable at shorter follow-ups.
The cause of CNV and its relation to ERM surgery is not entirely clear. It is intriguing that 3 of the 6 patients developed intraretinal or preretinal hemorrhaging in the perioperative period. While peeling the membrane from the macula, tractional forces transferred to the underlying retinal pigment epithelium and Bruch membrane could have resulted in a direct break or localized trauma reflected by areas of hemorrhaging. Causes for variable times of CNV onset postoperatively are uncertain, but may include the amount of induced trauma and the patient's predisposition to developing CNV.
Another possible explanation is that subclinical CNV coexisted with the ERM when the patient was initially seen. Gass5described 2 patients with idiopathic macular puckers who developed CNV years later and 1 patient who had an ERM and CNV on initial examination. However, the results of a fundus examination in our patients did not reveal any clinical signs of CNV before ERM surgery. In addition, 1 patient (case 2) underwent FA 1 month after ERM removal, which showed no hyperfluorescence in the macula.
We do not believe FA is necessary before performing ERM removal to rule out preexisting CNV. However, FA is valuable in examining patients postoperatively when they develop a decreased VA and metamorphopsia. Because of the limited number of reported cases, there is no consensus about the best treatment modality. Each patient should be examined and treated based on the CNV characteristics and available treatment options.
In summary, CNV is a rare complication of ERM surgery that is likely secondary to iatrogenic trauma that is transferred to the outer retina and Bruch membrane during ERM removal. Ophthalmologists who perform ERM surgery should consider CNV a possible cause of poor visual outcome in the early and late postoperative periods.
Correspondence: Dr Loewenstein, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA 02114-3096 (email@example.com).
Author Contributions: Drs Warden and Pachydaki contributed equally to this article.
Financial Disclosure: None reported.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.